Jun 24, 2026 04:06PM
Jun 24, 2026 04:05PM
Apr 21, 2026 09:04AM
Apr 21, 2026 07:06AM
Apr 21, 2026 03:20AM
Apr 20, 2026 09:02AM
Apr 20, 2026 07:03AM Passage Bio reports interim trial data, initiates strategic review
Apr 20, 2026 07:00AM
Apr 20, 2026 07:00AM
Mar 31, 2026 02:12AM
Mar 30, 2026 04:02PM
Nov 10, 2025 04:15PM
Jan 10, 2025 07:11AM
Jan 10, 2025 07:00AM Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
Aug 8, 2024 07:00AM
Jul 16, 2024 07:00AM
Jul 16, 2024 07:00AM
May 14, 2024 07:00AM
Aug 7, 2023 07:07AM
Aug 7, 2023 07:00AM
Feb 24, 2023 07:01AM Passage Bio (PASG) Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis
Feb 24, 2023 07:00AM
Feb 24, 2023 07:00AM
Feb 15, 2023 07:00AM
Feb 15, 2023 07:00AM
Dec 14, 2022 07:10AM
Dec 14, 2022 07:00AM
Dec 14, 2022 07:00AM Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM
Jun 8, 2022 07:30AM
Jun 8, 2022 07:30AM
Jun 8, 2022 07:30AM Passage Bio Receives FDA Clearance of IND Application for PBML04 for Treatment of Metachromatic Leukodystrophy
May 18, 2022 07:02AM
May 18, 2022 07:00AM
May 18, 2022 07:00AM
May 16, 2022 07:00AM
May 16, 2022 07:00AM
May 2, 2022 04:01PM
May 2, 2022 04:01PM Passage Bio to Present Updated Imagine-1 Study Clinical and Biomarker Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
Mar 29, 2022 07:02AM
Mar 29, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 10, 2022 07:00AM
Mar 10, 2022 07:00AM
Feb 11, 2022 11:00AM
Feb 11, 2022 11:00AM Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
Feb 11, 2022 11:00AM

325,028 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All